Statistics on Biotechnology Use Results by fields of operation Business Sector Biotechnology indicators by relevance of biotechnology to company activity. Unidades: specified in variables Total Main Secondary dwellings Tool Companies that carry out R&D in Biotechnology 1.299 559 230 510 %Companies according to biotechnology used: Genetic code 30,8 39,2 31,4 21,3 %Companies according to biotechnology used: Functional units 38,4 45,7 43 28,3 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 21,5 26,3 19,8 17,1 %Companies according to biotechnology used: Bioprocesses 50,8 40,7 54,3 60,2 %Companies according to biotechnology used: Sub-cellular organisms 8,5 12,7 4,6 5,6 %Companies according to biotechnology used: Bio-computing 24 34,7 22,1 13,2 %Companies according to biotechnology used: Nanobiotechnology 12,1 15,6 15,6 6,6 %Companies according to biotechnology used: Other 16,9 19,2 20,6 12,7 %Company by field(s) of ultimate application of biotechnology use: Human Health 45,5 64,2 36,9 28,8 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 15,5 17,4 16 13,1 %Company by field(s) of ultimate application of biotechnology use: Food products 32,3 21 34,5 43,8 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 23,8 20,7 30,9 23,9 %Company by field(s) of ultimate application of biotechnology use: Environment 15,6 14,1 24 13,5 %Company by field(s) of ultimate application of biotechnology use: Industry 13,7 14,7 18,5 10,6 Personnel in R&D in biotechnology (no. of persons) 15.750 6.759 3.644 5.347 Personnel in R&D in biotechnology (no. of persons): Research personnel 8.379 3.802 2.145 2.433 Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel 7.371 2.957 1.500 2.914 Personnel in R&D in biotechnology (no. of persons). Women 8.711 3.890 2.040 2.782 Personnel in R&D in biotechnology (no. of persons). Women: Research personnel 4.510 2.078 1.196 1.236 Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel 4.200 1.811 843 1.546 Personnel in R&D in biotechnology (FTE) 11.528,6 5.389 2.417,3 3.722,4 Personnel in R&D in biotechnology (FTE): Research personnel 6.342,7 3.157 1.493,6 1.692,1 Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel 5.185,9 2.232 923,7 2.030,3 Personnel in R&D in biotechnology (FTE). Women 6.539,7 3.168,1 1.378,1 1.993,6 Personnel in R&D in biotechnology (FTE). Women: Research personnel 3.455,7 1.734,1 839,4 882,2 Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel 3.084 1.434 538,7 1.111,4 Internal expenditure on R&D (thousands of euros) 1.038.582 519.104 204.849 314.630 1) By nature of the expense: Current expenses 940.091 466.051 179.259 294.780 1.1) Remuneration to research personnel 321.570 164.629 73.301 83.640 1.2) Remuneration to technicians and auxiliary personnel 194.836 85.747 33.173 75.916 1.3) Other current expenses 423.685 215.675 72.786 135.225 2) By nature of the expense: Capital expenses 98.492 53.052 25.589 19.850 2.1) Land and buildings 10.199 5.434 2.616 2.149 2.2) Equipment and instruments 72.584 36.725 20.086 15.773 2.3) Acquisition of specific R+D software 5.721 2.513 2.103 1.104 2.4) Otros productos de propiedad intelectual específicos para I+D 9.987 8.379 784 823 1.1) By origin of the funds: Own funds 711.488 314.308 155.688 241.492 1.2) By origin of the funds: From companies 121.738 80.154 10.983 30.601 1.3) By origin of the funds: Public Administration funds 107.477 61.083 16.108 30.285 1.4) By origin of the funds: From Universities 192 68 14 111 1.5) By origin of the funds: From non profit private institutions 10.756 9.444 0 1.312 1.6) By origin of the funds: Foreign funds 86.931 54.046 22.055 10.829 Purchase of R&D services in biotechnology (thousands of euros) 145.557 105.405 16.127 24.025 Purchase of R&D services in biotechnology (thousands of euros): In Spain 95.915 74.486 14.004 7.425 Purchase of R&D services in biotechnology (thousands of euros): Abroad 49.642 30.919 2.123 16.600 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 40,2 49,4 39,8 30,4 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 13,2 12,5 15,9 12,7 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 19 21,5 20 15,7 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 11,5 10,4 15,1 11,1 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets 15,9 16,1 23,5 12,1 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels 17 20,6 19,3 11,9 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception 16,4 16,3 23,1 13,6 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 40,5 46,9 44,1 31,9 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost 55 65,2 55,1 43,8 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 21,9 24,5 25 17,6 % Companies with income of an international origin related to biotechnological activities 23,5 33,3 19,8 14,4 % Turnover representing income of an international origin related to biotechnological activities 1,9 12,1 1,2 1,3 % Income of an international origin related to biotechnological activities distributed in: Income received from the EU 61,6 44 79,9 60,4 % Income of an international origin related to biotechnological activities distributed in: Income received from other countries 38,4 56 20,1 39,6 % Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services 87,6 97 73,4 96,5 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 10,9 1,5 25,9 0,9 % Income of an international origin related with activities according to the classification: Operating source abroad 1,1 1,3 0,7 1,3 % Income of an international origin related with activities according to the classification: Other 0,4 0,2 0 1,3 Notas: '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute